Total Voting Rights

DUBLIN, Ireland, and Boston M A, January 4, 202 2, Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, announces that on December 31, 2021 the issued share capital of the Company comprised 319,814,747 ordinary shares of 6 pence each. The Company does not hold any...